Association studies between-1185A/G von Willebrand factor gene polymorphism and coronary artery disease

Brazilian Journal of Medical and Biological Research

Volumn 36, Issue 6, 2003, Pages 709-714

  Simon, D ^a   Paludo, C A ^a   Ghisleni, G C ^a   Manfroi, W C ^b   Roisenberg, I ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Coronary artery disease; DNA polymorphisms; Risk factor; von Willebrand factor

Indexed keywords

ADENINE; GUANINE; RESTRICTION ENDONUCLEASE; VON WILLEBRAND FACTOR;

ADULT; AGED; ALLELE; ANGIOCARDIOGRAPHY; ARTICLE; BRAZIL; CAUCASIAN; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN BLOOD LEVEL; RISK FACTOR;

EID: 0038784548     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2003000600005     Document Type: Article

References (28)

1. Lip GY & Blann AD (1995). von Willebrand factor and its relevance to cardiovascular disorders. British Heart Journal, 74: 580-583.
2. Jansson JH, Nilssin TK & Johnson O (1991). von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. British Hearth Journal, 66: 351-355.
3. Meade TW, Cooper JA, Stirling Y, Howarth DJ, Ruddock V & Miller GJ (1994). Factor VIII, ABO blood group, and the incidence of ischaemic heart disease. British Journal of Haematology, 88: 601-607.
4. Montalescot G, Ankri A, Vicaut E, Drobinski G, Grosgogeat Y & Thomas D (1995). Fibrinogen after coronary angioplasty as a risk factor for restenosis. Circulation, 92: 31-38.
5. Thompson SG, Kienast J, Pyke SDM, Haverkate F & van de Loo JCW for the European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group (1995). Hemostatic factor and the risk of myocardial infarction or sudden death in patients with angina pectoris. New England Journal of Medicine, 332: 635-641.
6. Catto AJ, Carter AM, Barrett JH, Bamford J, Rice PJ & Grant PJ (1997). von Willebrand factor and factor VIII:C in acute cerebrovascular disease: relationship to stroke subtype and mortality. Thrombosis and Haemostasis, 77: 1104-1108.
7. Folsom AR, Rosamond WD, Shahar E, Cooper LS, Aleksic N, Nieto FJ, Rasmussen ML & Wu KK (1999). Prospective study of markers of hemostatic function with risk of ischemic stroke. Circulation, 100: 736-742.
8. Rumley A, Lowe GDO, Sweetnam PM, Yarnell JWG & Ford RP (1999). Factor VIII, von Willebrand factor and the risk of major ischaemic heart disease in the Caerphilly Heart Study. British Journal of Haematology, 105: 110-116.
9. Nielsen NE, Siegbahn A & Swan E (2000). Markers of hypercoagulation and von Willebrand factor in postmenopausal women with unstable coronary artery disease. Discriminatory ability regarding unstable coronary artery disease and coronary atherosclerosis using receiver operating characteristics. Journal of Internal Medicine, 248: 151-158.
10. Sakai H, Goto S, Kim A Aoki N, Abe S, Ichikawa N, Yoshida M, Nagaoka Y & Handa S (2000). Plasma concentration of von Willebrand factor in acute myocardial infarction. Thrombosis and Haemostasis, 84: 204-209.
11. Wiman B, Andersson T, Hallqvist J, Reuterwall C, Ahlbom A & deFaire U (2000). Plasma levels of tissue plasminogen activator/ plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study. Arteriosclerosis, Thrombosis, and Vascular Biology, 20: 2019-2023.
12. Heywood DMH, Ossei-Gerning N & Grant PJ (1997). Two novel polymorphisms of the von Willebrand factor gene promoter and association with ischaemic heart disease. Thrombosis and Haemostasis, 77 (Suppl): S375 (Abstract).
13. Tompkins K, Cameron C, Brady J, Raj S, Keightley A & Lillicrap D (1999). Polymorphisms in the glycoprotein lbα, α2 integrin and von Willebrand factor genes: possible implications in platelet adhesion and acute coronary events. Blood, 94 (Suppl 1): 71B (Abstract).
14. Lacquemant C, Gaucher C, Delorme C et al. (2000). Association between high von Willebrand factor levels and the Thr789Ala vWF gene polymorphism but not with nephropathy in type I diabetes. Kidney International, 57: 1437-1443.
15. Di Bitondo R, Cameron CL, Daly ME, Croft SA, Steeds RP, Channer KS, Samani NJ, Lillicrap D & Winship PR (2001). The -1185 A/G and -1051 G/A dimorphisms in the von Willebrand factor gene promoter and risk of myocardial infarction. British Journal of Haematology, 115: 701-706.
16. Dai K, Gao W & Ruan C (2001). The Smal polymorphism in the von Willebrand factor gene associated with acute ischemic stroke. Thrombosis Research, 104: 389-395.
17. Keightley AM, Lam YM, Brady JN, Cameron CL & Lillicrap D (1999). Variation at the von Willebrand factor (vWF) gene locus is associated with plasma vWF:Ag levels: identification of three novel single nucleotide polymorphisms in the vWF gene promoter. Blood, 93: 4277-4283.
18. Harvey PJ, Keightley AM, Lam YM, Cameron C & Lillicrap D (2000). A single nucleotide polymorphism at nucleotide -1793 in the von Willebrand factor (VWF) regulatory region is associated with plasma VWF:Ag levels. British Journal of Haematology, 109: 349-353.
19. Lahiri DK & Nurnberger Jr JI (1991). A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Research, 19: 5444.
20. Simon D, Palatnik M & Roisenberg I (2002). Analysis of the -1185A/G von Willebrand factor (VWF) gene polymorphism in two Brazilian ethnic groups and its effect on plasma VWF levels. Thrombosis Research, 105: 519-522.
21. Fischer RR, Lucas EM, Pereira AMB & Roisenberg I (1996). Preparation of a heterologous antiserum for the determination of von Willebrand factor in human plasma. Brazilian Journal of Medical and Biological Research, 29: 1641-1644.
22. Lane DA & Grant PJ (2000). Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood, 95: 1517-1532.
23. Franco RF & Reistma PH (2001). Gene polymorphisms of the haemostatic system and the risk of arterial thrombotic disease. British Journal of Haematology, 115: 491-506.
24. Orstavik K, Magnus P, Reisner H, Berg K, Graham J & Nance W (1985). Factor VIII and factor IX in a twin population. Evidence for a major effect of ABO locus on factor VIII level. American Journal of Human Genetics, 37: 89-101.
25. Gill JC, Endres-Brooks J, Bauer PJ, Marks Jr WJ & Montgomery RR (1987). The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood, 69: 1691-1695.
26. Shima M, Fujimura Y, Nishiyama T, Tsujiuchi T, Narita N, Matsui T, Titani K, Katayama M, Yamamoto F & Yoshioka A (1995). ABO blood group genotype and plasma von Willebrand factor in normal individuals. Vox Sanguinis, 68: 236-240.
27. Kamphuisen PW, Houwing-Duistermaat JJ, van Houwelingen HC, Eikenboom JCJ, Bertina RM & Rosendaal FR (1998). Familial clustering of factor VIII and von Willebrand factor levels. Thrombosis and Haemostasis, 79: 323-327.
28. Souto JC, Almsay L, Muniz-Diaz E et al. (2000) Functional effects of the ABO locus polymorphism on plasma levels of von Willebrand factor, factor VIII, and activated partial thromboplastin time. Arteriosclerosis, Thrombosis, and Vascular Biology, 20: 2024-2028.